Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin
NCT03758235
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Overactive Bladder Syndrome
Interventions
DRUG:
IncobotulinumtoxinA 100 UNT Injection [Xeomin]
DRUG:
OnabotulinumtoxinA 100 UNT [Botox]
Sponsor
University Of Perugia